Doxazosin Mesylate
Overview
Doxazosin Mesylate is an alpha-1 adrenergic blocker used primarily to treat hypertension and benign prostatic hyperplasia. It relaxes blood vessels and muscles in the prostate and bladder neck, making it easier to urinate and lower blood pressure.
API suppliers (8)
Suppliers of Doxazosin Mesylate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 8 suppliers.
2 of 8 hold a GMP certificate on record in the EU or UK registers
- EXCELLA GMBH AND CO KGGermany1 active DMF
- Wockhardt UsaUnited Kingdom
- Cipla USA, Inc.USA
- MEDICHEM SASpain GMP on record
- BASF PHARMACHEMIKALIEN GMBH CO KG
- CILAG AGSwitzerland GMP on record
- STANDARD CHEM AND PHARM CO LTD
- PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTD
Therapeutic areas
Do you supply Doxazosin Mesylate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.